We have located links that may give you full text access.
Al solubility in (Ti 1-c Al c )NiSn half-Heusler alloy.
Physical Chemistry Chemical Physics : PCCP 2019 March 22
Half-Heusler, HH, alloys are widely used n-type materials in thermoelectric applications. Today, there is a shortage in p-type HH based materials, which may have an inherent compatibility with the HH n-type pair. Al is a good candidate as an acceptor doping element for this purpose, and the results on alloying of TiNiSn-based HH with Al are reported in details. Combination of CALPHAD and ab initio DFT calculations with an experimental validation was carried out. It is demonstrated that low level Al doping leads to p-type conductivity of the material. The solubility of Al was predicted by calculations and experimentally confirmed. The stable phases with compositions above the solubility limit of Al were determined, including an assessment of the maximal Al solubility in the HH (Ti1-cAlc)NiSn phase up to 1400 K. In addition, a Scheil solidification simulation with the known TiNiSn CALPHAD database was used, in order to further understand the as-cast phase structure. It is shown that beyond the solubility limit the stable phases at room temperature are TiNiSn(HH), Sn(BCT) and NiAl(B2). The maximal solubility of Al in the HH phase is estimated as ∼1 at% at 1400 K. These results give the basic route for designing of (Ti1-cAlc)NiSn as a p-type thermoelectric element.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app